Botanical extract DCB-BO1301
Term · Oncology and biomedicine · MLC-T-ONC-012077
A proprietary botanical, galactolipid-enriched extract derived from the edible plant Crassocephalum crepidioides (Zhaohe Cao), with potential anti-inflammatory and antineoplastic activities. Upon oral administration, DCB-BO1301 may inhibit the growth of certain types of tumor cells, although the exact mechanism of action has yet to be fully elucidated.
| Identifier | MLC-T-ONC-012077 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | Zhaohe Cao-based botanical drug DCB-BO1301 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-012077",
"term": "Botanical extract DCB-BO1301",
"field": "Oncology and biomedicine",
"definition": "A proprietary botanical, galactolipid-enriched extract derived from the edible plant Crassocephalum crepidioides (Zhaohe Cao), with potential anti-inflammatory and antineoplastic activities. Upon oral administration, DCB-BO1301 may inhibit the growth of certain types of tumor cells, although the exact mechanism of action has yet to be fully elucidated.",
"synonyms": [
"Zhaohe Cao-based botanical drug DCB-BO1301"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/botanical-extract-dcb-bo1301/"
}
Record 3,755 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.